Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
Article
Published on
Journal: European Journal of Clinical Pharmacology [Category] COVID19(2023년), SARS, 신약개발, 치료제,
Journal: European Journal of Clinical Pharmacology [Category] COVID19(2023년), SARS, 신약개발, 치료제,
[키워드] absence
antidepressant
antidepressants
antiviral drug
approved
article
benefit
Care
Clinical outcome
clinical trial
coronavirus
COVID
COVID-19
database
death
decrease
drug
effort
Hospitalization
Infection
infections
information
inhibit
inhibitor
Intensive
intubation
methodological flaws
Mild-to-moderate
mortality rates
Novel coronavirus
pandemic
patients
receptor
Redirection
reduce
reported
repositioning
Repositioning.
Research
risk
SARS-CoV-2
SciELO
selective
Serotonin
shown
specific treatment
therapeutic intervention
Toxicity
treat
Treatment
viral titer
was performed
[DOI] 10.1007/s00228-022-03372-5 PMC 바로가기
[DOI] 10.1007/s00228-022-03372-5 PMC 바로가기